DRTS Valuation

Alpha Tau Medical Ltd

Add to Watchlist

Advanced Chart

2.595

-0.025(-0.950%)

Overview
Forecast
Valuation

DRTS Relative Valuation

DRTS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DRTS is overvalued; if below, it's undervalued.

Historical Valuation

Alpha Tau Medical Ltd (DRTS) is now in the Fair zone, suggesting that its current forward PS ratio of 567.38 is considered Fairly compared with the five-year average of 300.06. The fair price of Alpha Tau Medical Ltd (DRTS) is between 1.39 to 2.60 according to relative valuation methord.

Relative Value

Fair Zone

1.39-2.60

Current Price：2.60

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.91

P/B

Median3y

2.97

Median5y

-2.78

-11.94

FCF Yield

Median3y

-5.79

Median5y

-4.97

Competitors Valuation Multiple

The average P/S ratio for DRTS's competitors is 194.01, providing a benchmark for relative valuation. Alpha Tau Medical Ltd Corp (DRTS) exhibits a P/S ratio of 567.38, which is 192.44% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

DRTS.O

Alpha Tau Medical Ltd

567.38

Average P/S: 194.01

219.25M